Fundamental Analysis of OMNIAB INC(NASDAQ:OABI) stock

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to OABI. OABI was compared to 55 industry peers in the Life Sciences Tools & Services industry. No worries on liquidiy or solvency for OABI as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, OABI is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

OABI had negative earnings in the past year.

In the past year OABI has reported a negative cash flow from operations.

OABI had negative earnings in each of the past 5 years.

The reported operating cash flow has been mixed in the past 5 years: OABI reported negative operating cash flow in multiple years.

1.2 Ratios

The Return On Assets of OABI (-19.01%) is worse than 60.00% of its industry peers.

OABI's Return On Equity of -21.60% is in line compared to the rest of the industry. OABI outperforms 47.27% of its industry peers.

		Industry Rank	Sector Rank
ROA	-19.01%
ROE	-21.6%
ROIC	N/A

ROA(3y)-9.22%

ROA(5y)N/A

ROE(3y)-11.39%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

OABI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

OABI does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, OABI has more shares outstanding

There is no outstanding debt for OABI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 6.06 indicates that OABI is not in any danger for bankruptcy at the moment.

With an excellent Altman-Z score value of 6.06, OABI belongs to the best of the industry, outperforming 83.64% of the companies in the same industry.

OABI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	6.06

ROIC/WACCN/A

WACC11.26%

2.3 Liquidity

A Current Ratio of 4.62 indicates that OABI has no problem at all paying its short term obligations.

OABI has a Current ratio of 4.62. This is in the better half of the industry: OABI outperforms 67.27% of its industry peers.

OABI has a Quick Ratio of 4.62. This indicates that OABI is financially healthy and has no problem in meeting its short term obligations.

Looking at the Quick ratio, with a value of 4.62, OABI is in the better half of the industry, outperforming 78.18% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	4.62
Quick Ratio	4.62

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for OABI have decreased strongly by -93.75% in the last year.

OABI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -68.46%.

OABI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.66% yearly.

EPS 1Y (TTM)-93.75%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%0%

Revenue 1Y (TTM)-68.46%

Revenue growth 3Y13.66%

Revenue growth 5YN/A

Sales Q2Q%-23.86%

3.2 Future

The Earnings Per Share is expected to grow by 8.99% on average over the next years. This is quite good.

The Revenue is expected to grow by 21.52% on average over the next years. This is a very strong growth

EPS Next Y-10.13%

EPS Next 2Y11.79%

EPS Next 3Y14.85%

EPS Next 5Y8.99%

Revenue Next Year-15.35%

Revenue Next 2Y20.58%

Revenue Next 3Y24.64%

Revenue Next 5Y21.52%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

OABI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year OABI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

OABI's earnings are expected to grow with 14.85% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y11.79%

EPS Next 3Y14.85%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

OABI does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

OMNIAB INC

NASDAQ:OABI (11/21/2024, 8:00:02 PM)

After market: 3.85 0 (0%)

3.85

-0.05 (-1.28%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryLife Sciences Tools & Services

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap462.85M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-19.01%
ROE	-21.6%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.06

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	4.62
Quick Ratio	4.62
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-93.75%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y-10.13%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-68.46%

Revenue growth 3Y13.66%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

OMNIAB INC (OABI)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens